Thomas Brendler, R. Al‐Mondhiry, L. Lang, Robin J. Marles, Mark J. Tallon, A. V. Raghu
Over the last decade, ashwagandha ( Withania somnifera (L.) Dunal, AS) has been brought under increasing scrutiny by EU regulators regarding its safety for the use in food supplements, culminating in a recent recommendation for an Article 8 procedure according to Regulation (EC) No. 1925/2006 in the European Union (EU). Once executed, this could lead to a ban on its use as an ingredient in food supplements. This review summarizes how AS is regulated in some of the primary world marketplaces.